Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Chemical Biology is Scopus-indexed (Q2, CiteScore 1.7), DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 2813-530XVerify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 28 / 57 | 51st | Q2 |
| Chemistry (miscellaneous) | 107 / 137 | 22nd | Q4 |
| Structural Biology | 48 / 51 | 6th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q2, CiteScore 1.7.
Frontiers in Chemical Biology is Q2 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 28 of 57), Q4 in Chemistry (miscellaneous) (rank 107 of 137) and Q4 in Structural Biology (rank 48 of 51), by CiteScore 2025.
Frontiers in Chemical Biology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.7, quartile Q2, 51st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.435, quartile Q2, with an H-index of 6.
The publisher lists an article processing charge of about US$2,353 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Chemical Biology is published by Frontiers Media SA. Its ISSN is 2813-530X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Chemical Biology has an h-index of 10 and a 2-year mean of 3.15 citations per paper (OpenAlex). Its Scopus CiteScore is 1.7, quartile Q2. On 2-year citations it ranks #13 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Frontiers in Chemical Biology published 31 papers in 2025; its busiest recent year was 2024 with 33. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from United States (24.9%), Italy (16.1%) and Japan (5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.